Skip to main content
Clinical Trials/ITMCTR1900002555
ITMCTR1900002555
Not yet recruiting
未知

Identification of biomarkers and pathogenesis of lung cancer without targeted metabolomics based on uplc-q-tof /MS

The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine0 sitesTBD
Conditionsung cancer

Overview

Phase
未知
Intervention
Not specified
Conditions
ung cancer
Sponsor
The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Basic Science
Sex
All

Investigators

Sponsor
The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. in line with the standard of diagnosis and treatment of common malignant tumors compiled by the medical department of the People's Republic of China,Patients with lung malignancy diagnosed by pathology or cytology;
  • 2\. the survival period was estimated to be more than 3 months. In general, Karnorfsy\=30 points, ecog\-ps \<\=4 points;
  • 3\. aged 18\-80 years old;
  • 4\. stop radiation and chemotherapy \> for 2 months;
  • 5\. patients are willing to accept the program, compliance.

Exclusion Criteria

  • 1\. does not meet the inclusion criteria;
  • 2\. pregnant or lactating women;
  • 3\. combined with serious cardiovascular and cerebrovascular diseases, or mental disorders and other diseases;
  • 4\. participate in other clinical trials;
  • 5\. Poor compliance.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Identification and analysis of biomarkers for the course of demyelinating and inflammatory diseases of the central nervous system, in particular multiple sclerosisDemyelinating and inflammatory diseases of the central nervous system, in particular multiple sclerosis
DRKS00031139MPI-NAT1,000
Recruiting
Not Applicable
Clinical, molecular and functional biomarkers for PROgnosis, pathomechanisms and treatment strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)Coronavirus Disease 19 (COVID-19)U07.1J12J13J14J15J16J17J18COVID-19, virus identifiedViral pneumonia, not elsewhere classifiedPneumonia due to Streptococcus pneumoniaePneumonia due to Haemophilus influenzaeBacterial pneumonia, not elsewhere classifiedPneumonia due to other infectious organisms, not elsewhere classifiedPneumonia in diseases classified elsewherePneumonia, organism unspecified
DRKS00022871CAPNETZ STIFTUNG, Geschäftsstelle an der Medizinischen Hochschule Hannover400
Completed
Not Applicable
Clinical, molecular and functional biomarkers for PROgnosis, pathomechanisms and treatment strategies of COVID-19 (PROVID) - (PROVID-PROGRESS)U07.1J12J13J14J15J16J17J18COVID-19, virus identifiedViral pneumonia, not elsewhere classifiedPneumonia due to Streptococcus pneumoniaePneumonia due to Haemophilus influenzaeBacterial pneumonia, not elsewhere classifiedPneumonia due to other infectious organisms, not elsewhere classifiedPneumonia in diseases classified elsewherePneumonia, organism unspecified
DRKS00023277Charité – Universitätsmedizin Berlin, Med. Klinik m. S. Infektiologie und Pneumologie, und Arbeitsbereich Pulmonale Inflammation94
Recruiting
Not Applicable
Identification of risk factors and biomarkers for liver diseases, hepatocellular carcinoma, cholangiocarcinoma and gallbladder carcinoma. The ESCALON stduy.
NL-OMON48295Erasmus MC, Universitair Medisch Centrum Rotterdam1,950
Recruiting
Not Applicable
Testing novel biomarkers for the diagnosis of the delayed sleep wake phase disorder (DSWPD) in young adultsG47Sleep disorders
DRKS00030981Charitè Universitätmedizin (Chronobiology Lab)32